| ORIGINAL ARTICLE |
|
| Year : 2019 | Volume
: 18
| Issue : 1 | Page : 20-23 |
|
|
Determination of carbohydrate antigen 19-9 level in Sera of Iraqi patients with type 2 diabetes mellitus
Russul Riedh Al-Hamaoy1, Hassan H Al-Saeed1, Mahmood Shakir Khudhair2
1 Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University, Baghdad, Iraq
2 Department of Internal Medicine and Endocrinology, College of Medicine, Al-Nahrain University, Baghdad, Iraq
Correspondence Address:
Russul Riedh Al-Hamaoy
Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University, Baghdad
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/MJ.MJ_10_18
|
|
|
Background: Diabetes mellitus is a major medical problem worldwide that can be qualified as the last stage of chronic pancreatitis; on the other hand, chronic pancreatitis is considered as a risk factor for pancreatic cancer. Therefore, the evaluation of carbohydrate antigen 19-9 (CA 19-9) level in patients with diabetes mellitus makes it imperative to find normal range for CA 19-9 level for this patient to eliminate the additional interventional approaches. Objectives: The objectives of this study were to define the normal range (cutoff value) of CA 19-9 in type 2 diabetic patients using enzyme-linked immunosorbent assays. Materials and Methods: This study included 80 patients diagnosed as type 2 diabetes mellitus (T2DM) with mean age (46.5625 ± 1.1054 years) who were divided into two groups. In Group I, 40 patients with T2DM have a mean duration of (6.6 ± 0.9421 years) and take medication. Group II consisted of 40 patients who were newly diagnosed with type 2 diabetic and do not take medication. Totally, 40 healthy individuals with mean age (44.7 ± 1.4539) were classified as the control group. Results: The mean ± standard error (SE) serum level of CA 19-9 in patients with T2DM in Groups I and II was 30.22933 ± 3.2434 U/ml and 32.58443 ± 2.7997 U/ml, respectively, which was significantly higher than the mean ± SE serum level in control group (6.4328 ± 1.3087 U/ml). When using a serum CA 19-9 concentration of 49.5 U/ml as a cutoff value to differentiate between T2DM and pancreatic cancer, sensitivity was 88.8% and specificity 77.5%. Conclusion: Define the normal range (cutoff value) of CA 19-9 in type 2 diabetic patients is useful in discriminating pancreatic cancer patients from type 2 diabetic patients.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
